Treatment of Asymptomatic Bacteriuria
Asymptomatic bacteriuria should NOT be treated in the vast majority of patients, with only two clear exceptions: pregnant women and patients undergoing endoscopic urologic procedures with mucosal trauma. 1
Do NOT Screen or Treat in These Populations
The following groups should not receive screening or treatment for asymptomatic bacteriuria, as treatment provides no benefit and causes harm:
General Adult Populations
- Healthy premenopausal, nonpregnant women (strong recommendation, moderate-quality evidence) 1
- Healthy postmenopausal women (strong recommendation, moderate-quality evidence) 1
- Men of any age (strong recommendation, moderate-quality evidence) 1
- Older adults in community or long-term care facilities (strong recommendation, moderate-quality evidence) 1
Specific Medical Conditions
- Patients with diabetes mellitus (strong recommendation, moderate-quality evidence) 1
- Renal transplant recipients beyond 1 month post-transplant (strong recommendation, high-quality evidence) 1
- Non-renal solid organ transplant recipients (strong recommendation, moderate-quality evidence) 1
- Spinal cord injury patients (strong recommendation, low-quality evidence) 1
- Children of all ages (strong recommendation, moderate-quality evidence) 1, 2
Catheter-Related Situations
- Short-term indwelling urethral catheters (<30 days) (strong recommendation, low-quality evidence) 1
- Long-term indwelling catheters (strong recommendation, low-quality evidence) 1
Surgical Patients
- Elective non-urologic surgery, including cardiac surgery with device implantation like LVAD (strong recommendation, low-quality evidence) 1, 3
- Joint replacement surgery (no benefit demonstrated) 4
DO Screen and Treat in These Two Situations
1. Pregnant Women
Screen all pregnant women with urine culture at 12-16 weeks gestation or at first prenatal visit if later (strong recommendation, high-quality evidence) 1
Treatment specifics:
- Duration: 4-7 days of antimicrobial therapy (weak recommendation, low-quality evidence) 1
- Single-dose therapy is less effective than 4-7 day courses 1
- Preferred agents: nitrofurantoin or β-lactams (ampicillin, cephalexin) due to pregnancy safety 1
- Fosfomycin single dose may be effective but has limited data in pregnancy 1
Rationale: Treatment reduces risk of pyelonephritis, preterm delivery, and low birthweight 1, 4
2. Endoscopic Urologic Procedures with Mucosal Trauma
Screen and treat before procedures like transurethral resection of prostate (strong recommendation, moderate-quality evidence) 1
Treatment specifics:
- Obtain urine culture before procedure and use targeted therapy rather than empiric treatment (weak recommendation, very low-quality evidence) 1
- Give 1-2 doses of antimicrobials rather than prolonged therapy (weak recommendation, low-quality evidence) 1
- Timing: Initiate 30-60 minutes before the procedure 1
- Continue until catheter removal if indwelling catheter remains post-procedure 1
Rationale: Bacteremia occurs in up to 60% and sepsis in 6-10% of bacteriuric patients undergoing transurethral prostatic resection without treatment 1
Critical Pitfalls to Avoid
Pyuria Is NOT an Indication for Treatment
The presence of pyuria with asymptomatic bacteriuria does NOT warrant treatment 1, 3. Pyuria does not reliably distinguish asymptomatic bacteriuria from symptomatic UTI and should be ignored in asymptomatic patients 1
Delirium in Elderly Patients
In older patients with bacteriuria and delirium but WITHOUT fever, dysuria, or hemodynamic instability, assess for other causes rather than treating the bacteriuria (strong recommendation, very low-quality evidence) 1. The same applies to elderly patients who fall 1
Device Implantation
For artificial urinary sphincter or penile prosthesis implantation, do NOT screen or treat asymptomatic bacteriuria (weak recommendation, very low-quality evidence) 1. Give standard perioperative prophylaxis instead 1, 3
Harms of Unnecessary Treatment
Treatment of asymptomatic bacteriuria when not indicated causes:
- Increased antimicrobial resistance 1, 5
- Clostridioides difficile infection 1, 5
- Adverse drug effects 1
- Increased risk of subsequent symptomatic UTI (paradoxically, treating stable bacteriuria may increase short-term pyelonephritis risk) 1, 2
- Unnecessary healthcare costs 5, 6
Knowledge Gaps
No clear recommendation exists for: